Two Biotechs I’m Buying Amid an Overbought Market
As retailers get hit and AI-plays bubble over, I’ve got my sights on these two promising biopharma stocks.
Charting Bitcoin
Looking at the chart for Bitcoin, readers will see two nearly simultaneous technical patterns running alongside each other that appear to be bullish in nature. There is a Falling Wedge pattern of bullish reversal that created the August breakout. We now also have a giant Double Bottom pattern, also of bullish reversal. That one may be a problem.
The pivot there sits at just about $81,700. This is close to where BTC appears to have hit resistance this morning. Should Bitcoin fail to take and hold that spot, this pattern will fail and the breakout is over.
Checking my favored indicators, Relative Strength appears to have apexed and has now entered into a technically overbought state. That said, below the chart, the daily MACD, which is a momentum indicator, looks really bullish.
The histogram of the 9-day EMA has been in positive territory since mid-August, which is a short-term bullish signal. On top of that, the 12-day EMA is running well above the 26-day EMA. With both of those lines still standing above the zero-bound, the bullish signal is amplified.
Everything really depends upon what happens at the $81,700 pivot point.
Position: None
How Meta Stock Turns to a Buy After $17 Billion Settlement
Retail investors should keep an eye on this line to determine what the pros are doing after the landmark settlement.
This Drone Stock Appears to Be Low-Hanging Fruit
As we get big news from the Meta case and await Nvidia earnings, here’s a company I’m adding to my shopping list.
Late Morning Tweet
Positions: None.
Big Software Stocks Are Languishing, But These 2 Disruptors Are on a Tear
I’m opening small positions in these names that are turning the software sector on its head.
The $10K Portfolio Is Out
Adding to Some Small-Cap Losers | TheStreet Pro
Positions: Long ASPN, ALTO, EVLV, OCUL, ONDS, PL, RKLB, SOFI, SWBI, VELO equity. Short OCUL calls.
Upgrading Our Meta Rating as Settlement News Removes Overhang
There are still multiple level of resistance ahead. Here’s how we’re playing the stock.